Search

everythinglearnresearchcommunity

for

Search:↓

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Syphilis has a wide range of symptoms that can look like other diseases, and if not treated, it can progress to a more serious stage, especially in HIV-positive patients.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Minoxidil effectively treats hair loss, with better results in women.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Skin organoids are a promising new model for studying human skin development and testing treatments.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Cyclosporine A promotes hair growth and prolongs the active growth phase in human hair follicles, but may work differently than in rodents.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Proper control of β-catenin activity is crucial for development and preventing diseases like cancer.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Cell-based therapies show promise for treating Limbal Stem Cell Deficiency but need more research.

People with Down's syndrome often have more skin problems due to a weak immune system.

Immune cells affect hair growth and could lead to new hair loss treatments.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Azelaic acid and anthralin are similarly effective for treating patchy hair loss.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Cheonggukjang may help prevent and manage various diseases and improve overall health, but its odor and safety concerns need addressing.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

New drugs for heart disease may be developed from molecules secreted by stem cells.